{"id":"https://openalex.org/W7225626197","doi":"https://doi.org/10.3389/fmed.2026.1947268","title":"Efficacy and safety of subsequent pharmacological therapies for previously treated adults with primary immune thrombocytopenia: a network meta-analysis and certainty-of-evidence assessment","display_name":"Efficacy and safety of subsequent pharmacological therapies for previously treated adults with primary immune thrombocytopenia: a network meta-analysis and certainty-of-evidence assessment","publication_year":2026,"publication_date":"2026-11-09","ids":{"openalex":"https://openalex.org/W7225626197","doi":"https://doi.org/10.3389/fmed.2026.1947268"},"language":"en","primary_location":{"id":"doi:10.3389/fmed.2026.1947268","doi":"https://doi.org/10.3389/fmed.2026.1947268","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fmed.2026.1947268","pdf_url":"https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2026.1947268/pdf","source":{"id":"https://openalex.org/S2597052008","display_name":"Frontiers in Medicine","issn_l":"2296-858X","issn":["2296-858X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Medicine","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2026.1947268/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5161320415","display_name":"Chaorong Zhang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114539943","display_name":"Zhejiang Chinese Medical University","ror":"https://ror.org/04epb4p87","country_code":"CN","type":"education","lineage":["https://openalex.org/I114539943"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Chaorong Zhang","raw_affiliation_strings":["The First School of Clinical Medicine, Zhejiang Chinese Medical University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The First School of Clinical Medicine, Zhejiang Chinese Medical University","institution_ids":["https://openalex.org/I114539943"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5144133679","display_name":"Wenquan Luo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114539943","display_name":"Zhejiang Chinese Medical University","ror":"https://ror.org/04epb4p87","country_code":"CN","type":"education","lineage":["https://openalex.org/I114539943"]},{"id":"https://openalex.org/I4210097783","display_name":"Tongde Hospital of Zhejiang Province","ror":"https://ror.org/00trnhw76","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210097783"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Wenquan Luo","raw_affiliation_strings":["Tongde Hospital of Zhejiang Province Affiliated to Zhejiang Chinese Medical University (College of Integrated Traditional Chinese and Western Medicine Clinical Medicine)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tongde Hospital of Zhejiang Province Affiliated to Zhejiang Chinese Medical University (College of Integrated Traditional Chinese and Western Medicine Clinical Medicine)","institution_ids":["https://openalex.org/I114539943","https://openalex.org/I4210097783"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5100535764","display_name":"Liming Yin","orcid":"https://orcid.org/0009-0002-8373-9398","observed_orcids":["https://orcid.org/0009-0002-8373-9398"]},"institutions":[{"id":"https://openalex.org/I114539943","display_name":"Zhejiang Chinese Medical University","ror":"https://ror.org/04epb4p87","country_code":"CN","type":"education","lineage":["https://openalex.org/I114539943"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Liming Yin","raw_affiliation_strings":["Fuyang Institiute of Zhejiang Chinese Medical University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fuyang Institiute of Zhejiang Chinese Medical University","institution_ids":["https://openalex.org/I114539943"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5100535764"],"corresponding_institution_ids":["https://openalex.org/I114539943"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"13","issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11064","display_name":"Antiplatelet Therapy and Cardiovascular Diseases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10693","display_name":"Blood transfusion and management","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/primary-immune-thrombocytopenia","display_name":"primary immune thrombocytopenia","score":0.9829999804496765},{"id":"https://openalex.org/keywords/relapsed-itp","display_name":"relapsed ITP","score":0.6430000066757202},{"id":"https://openalex.org/keywords/second-line-treatment","display_name":"second-line therapy","score":0.7409999966621399},{"id":"https://openalex.org/keywords/eltrombopag","display_name":"eltrombopag","score":0.9049999713897705},{"id":"https://openalex.org/keywords/romiplostim","display_name":"romiplostim","score":1.0},{"id":"https://openalex.org/keywords/avatrombopag","display_name":"avatrombopag","score":0.9900000095367432},{"id":"https://openalex.org/keywords/hetrombopag","display_name":"hetrombopag","score":0.9829999804496765},{"id":"https://openalex.org/keywords/fostamatinib","display_name":"fostamatinib","score":0.9810000061988831},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.984000027179718},{"id":"https://openalex.org/keywords/recombinant-human-thrombopoietin","display_name":"recombinant human thrombopoietin","score":0.9829999804496765},{"id":"https://openalex.org/keywords/platelet-responsiveness","display_name":"platelet response","score":0.9129999876022339},{"id":"https://openalex.org/keywords/bleeding-events","display_name":"bleeding events","score":0.7689999938011169},{"id":"https://openalex.org/keywords/salvage-therapy","display_name":"salvage therapy","score":0.8140000104904175},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.7760000228881836},{"id":"https://openalex.org/keywords/quality-of-evidence","display_name":"quality of evidence","score":0.7960000038146973}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9161999821662903},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.7174999713897705},{"id":"https://openalex.org/C2780588981","wikidata":"https://www.wikidata.org/wiki/Q411588","display_name":"Eltrombopag","level":4,"score":0.5537999868392944},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5404999852180481},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5403000116348267},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5077000260353088},{"id":"https://openalex.org/C2993327898","wikidata":"https://www.wikidata.org/wiki/Q638729","display_name":"Immune thrombocytopenia","level":3,"score":0.506600022315979},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.5037000179290771},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.42160001397132874},{"id":"https://openalex.org/C2776760755","wikidata":"https://www.wikidata.org/wiki/Q18939","display_name":"Azathioprine","level":3,"score":0.38339999318122864},{"id":"https://openalex.org/C82789193","wikidata":"https://www.wikidata.org/wiki/Q2142611","display_name":"Relative risk","level":3,"score":0.3619000017642975},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.3434999883174896},{"id":"https://openalex.org/C95190672","wikidata":"https://www.wikidata.org/wiki/Q815382","display_name":"Meta-analysis","level":2,"score":0.33309999108314514},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.3278999924659729},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.3109000027179718},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.2847999930381775},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.28200000524520874},{"id":"https://openalex.org/C2909112448","wikidata":"https://www.wikidata.org/wiki/Q721432","display_name":"Platelet aggregation inhibitor","level":3,"score":0.2815000116825104},{"id":"https://openalex.org/C2777849778","wikidata":"https://www.wikidata.org/wiki/Q410237","display_name":"Clopidogrel","level":3,"score":0.2793000042438507},{"id":"https://openalex.org/C205545832","wikidata":"https://www.wikidata.org/wiki/Q17156455","display_name":"Young adult","level":2,"score":0.2754000127315521},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2727000117301941},{"id":"https://openalex.org/C120195587","wikidata":"https://www.wikidata.org/wiki/Q2138790","display_name":"Absolute risk reduction","level":3,"score":0.27219998836517334},{"id":"https://openalex.org/C2776915898","wikidata":"https://www.wikidata.org/wiki/Q1235195","display_name":"Romiplostim","level":5,"score":0.26840001344680786},{"id":"https://openalex.org/C202953159","wikidata":"https://www.wikidata.org/wiki/Q382695","display_name":"Intention-to-treat analysis","level":3,"score":0.2678999900817871},{"id":"https://openalex.org/C67774102","wikidata":"https://www.wikidata.org/wiki/Q614132","display_name":"Number needed to treat","level":4,"score":0.26579999923706055},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.2606000006198883},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.250900000333786}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.3389/fmed.2026.1947268","doi":"https://doi.org/10.3389/fmed.2026.1947268","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fmed.2026.1947268","pdf_url":"https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2026.1947268/pdf","source":{"id":"https://openalex.org/S2597052008","display_name":"Frontiers in Medicine","issn_l":"2296-858X","issn":["2296-858X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Medicine","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.3389/fmed.2026.1947268","doi":"https://doi.org/10.3389/fmed.2026.1947268","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fmed.2026.1947268","pdf_url":"https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2026.1947268/pdf","source":{"id":"https://openalex.org/S2597052008","display_name":"Frontiers in Medicine","issn_l":"2296-858X","issn":["2296-858X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Medicine","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/systematic-review","display_name":"Systematic Review"},{"id":"https://openalex.org/study-designs/meta-analysis","display_name":"Meta-Analysis"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225626197.pdf","grobid_xml":"https://content.openalex.org/works/W7225626197.grobid-xml"},"referenced_works_count":49,"referenced_works":["https://openalex.org/W1489885552","https://openalex.org/W1531484155","https://openalex.org/W1617328014","https://openalex.org/W1977058832","https://openalex.org/W1981693350","https://openalex.org/W1984073642","https://openalex.org/W2003800151","https://openalex.org/W2013946336","https://openalex.org/W2047557050","https://openalex.org/W2066976900","https://openalex.org/W2119920607","https://openalex.org/W2122735473","https://openalex.org/W2137716967","https://openalex.org/W2145439228","https://openalex.org/W2153670291","https://openalex.org/W2156817733","https://openalex.org/W2179600628","https://openalex.org/W2531180061","https://openalex.org/W2799711263","https://openalex.org/W2891044782","https://openalex.org/W2902028302","https://openalex.org/W2910592284","https://openalex.org/W2944617176","https://openalex.org/W2969629827","https://openalex.org/W2978636067","https://openalex.org/W2993666578","https://openalex.org/W3011743134","https://openalex.org/W3015163167","https://openalex.org/W3042142853","https://openalex.org/W3133256211","https://openalex.org/W3158430680","https://openalex.org/W3185682299","https://openalex.org/W3201065583","https://openalex.org/W4211106014","https://openalex.org/W4246837663","https://openalex.org/W4255910801","https://openalex.org/W4312211008","https://openalex.org/W4317433604","https://openalex.org/W4320717310","https://openalex.org/W4377861238","https://openalex.org/W4381435228","https://openalex.org/W4385306498","https://openalex.org/W4385667588","https://openalex.org/W4404063959","https://openalex.org/W4408492440","https://openalex.org/W4413400588","https://openalex.org/W4414620902","https://openalex.org/W4417018316","https://openalex.org/W7140190522"],"related_works":["https://openalex.org/W2910592284","https://openalex.org/W2969629827","https://openalex.org/W4383554217","https://openalex.org/W2902028302","https://openalex.org/W2894236857","https://openalex.org/W4311443213","https://openalex.org/W2043512555","https://openalex.org/W4312211008","https://openalex.org/W3211294343","https://openalex.org/W2078644313"],"abstract_inverted_index":{"Background":[0],"Adult":[1],"primary":[2,44,83,130,336],"immune":[3,45],"thrombocytopenia":[4,46],"(ITP)":[5],"often":[6],"relapses":[7],"after":[8],"first-line":[9],"corticosteroid":[10],"therapy,":[11,147],"but":[12,338],"comparative":[13],"evidence":[14,53,170,354],"for":[15,39,54,312],"subsequent":[16,36,97,323],"pharmacological":[17,37,98,324],"therapies":[18,38,325],"in":[19,77,212,331],"previously":[20,40,87,332],"treated":[21,41,333],"adults":[22,42,78,334],"remains":[23],"fragmented.":[24],"Objective":[25],"To":[26],"compare":[27],"the":[28,50,209],"relative":[29],"efficacy":[30],"and":[31,47,70,94,103,124,151,167,182,199,218,261,297,314,351],"safety":[32],"of":[33,52,73,105,169,230,353],"currently":[34],"available":[35],"with":[43,79,162,189,226,306,335],"to":[48,111,197,206,240,254,327],"assess":[49],"certainty":[51,168,352],"clinically":[55],"relevant":[56],"treatment":[57,93,184,268],"comparisons":[58],"using":[59,173],"a":[60,67,227,270],"network":[61,71,156],"meta-analysis":[62,72,157],"framework.":[63],"Methods":[64],"We":[65],"performed":[66],"systematic":[68],"review":[69],"randomized":[74,177],"controlled":[75],"trials":[76,178],"persistent":[80],"or":[81],"chronic":[82],"ITP":[84],"who":[85],"had":[86],"received":[88],"at":[89],"least":[90],"one":[91],"ITP-directed":[92],"were":[95,107,144,186,304,319],"receiving":[96],"therapy.":[99],"PubMed,":[100],"Embase,":[101],"CENTRAL,":[102],"Web":[104],"Science":[106],"searched":[108],"from":[109],"inception":[110],"July":[112],"1,":[113],"2026.":[114],"Eligible":[115],"interventions":[116],"included":[117],"eltrombopag,":[118],"romiplostim,":[119,216],"avatrombopag,":[120],"hetrombopag,":[121,217],"fostamatinib,":[122],"rituximab,":[123],"recombinant":[125],"human":[126],"thrombopoietin":[127],"(rhTPO).":[128],"The":[129],"outcome":[131],"was":[132,171,224],"platelet":[133,213],"response":[134],"(platelet":[135],"count":[136],"\u226550":[137],"\u00d7":[138],"10":[139],"^":[140],"9/L).":[141],"Secondary":[142],"outcomes":[143],"bleeding,":[145],"rescue":[146,246],"any":[148,231,264],"adverse":[149,153,265,283],"event,":[150,266],"serious":[152,282],"events.":[154],"Random-effects":[155],"estimated":[158],"risk":[159,273],"ratios":[160],"(RRs)":[161],"95%":[163,194,203,237,251,288,294,301],"confidence":[164],"intervals":[165],"(CIs),":[166],"assessed":[172],"CINeMA.":[174],"Results":[175],"Twenty-two":[176],"involving":[179],"2,753":[180],"participants":[181],"eight":[183],"nodes":[185],"included.":[187],"Compared":[188],"placebo,":[190,275],"rhTPO":[191,244,277,313],"(RR":[192,201,235,249,286,292,299],"5.34,":[193],"CI":[195,204,238,252],"2.39":[196],"11.92)":[198],"avatrombopag":[200],"4.67,":[202],"2.10":[205],"10.39)":[207],"showed":[208,269],"largest":[210],"improvements":[211],"response,":[214],"while":[215],"eltrombopag":[219,285],"also":[220],"favored":[221],"treatment.":[222],"Fostamatinib":[223],"associated":[225,305],"lower":[228,307],"incidence":[229],"reported":[232],"bleeding":[233],"event":[234],"0.24,":[236],"0.07":[239,253],"0.79;":[241],"high-certainty":[242,256],"evidence).":[243],"reduced":[245,272],"therapy":[247,341],"use":[248],"0.18,":[250],"0.46;":[255,293],"evidence),":[257],"followed":[258],"by":[259],"hetrombopag":[260,291],"eltrombopag.":[262],"For":[263,281],"no":[267,339],"clearly":[271],"vs.":[274],"although":[276],"ranked":[278],"most":[279],"favorably.":[280],"events,":[284],"0.39;":[287],"CI,":[289,295,302],"0.26\u20130.58),":[290],"0.27\u20130.79),":[296],"romiplostim":[298],"0.65;":[300],"0.47\u20130.88)":[303],"risks":[308],"than":[309,356],"placebo.":[310],"Estimates":[311],"several":[315],"other":[316],"treatments,":[317],"however,":[318],"imprecise.":[320],"Conclusions":[321],"Different":[322],"appear":[326],"offer":[328],"outcome-specific":[329],"advantages":[330],"ITP,":[337],"single":[340],"dominated":[342],"all":[343],"endpoints.":[344],"Treatment":[345],"selection":[346],"should":[347],"integrate":[348],"efficacy,":[349],"safety,":[350],"rather":[355],"ranking":[357],"alone.":[358],"Systematic":[359],"Review":[360],"Registration":[361],"https://www.crd.york.ac.uk/PROSPERO/view/CRD420261455143":[362],",":[363],"identifier":[364],"PROSPERO":[365],"CRD420261455143.":[366]},"counts_by_year":[],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2026-11-10T00:00:00"}